| Dr Danielle Dawn Buda, MD | |
|
2001 Pine Lake Rd Ste 300, Lincoln, NE 68512-3631 | |
| (402) 447-7221 | |
| (402) 447-7222 |
| Full Name | Dr Danielle Dawn Buda |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 2001 Pine Lake Rd Ste 300, Lincoln, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205944949 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 23608 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Danielle Dawn Buda, MD 2001 Pine Lake Rd Ste 300, Lincoln, NE 68512-3631 Ph: (402) 447-7221 | Dr Danielle Dawn Buda, MD 2001 Pine Lake Rd Ste 300, Lincoln, NE 68512-3631 Ph: (402) 447-7221 |
News Archive
Bellicum Pharmaceuticals, Inc. today announced that the Company received notice of a $5.7 million company commercialization award from the Cancer Prevention and Research Institute of Texas ("CPRIT"). Bellicum was the only company recommended for funding in this second round of the commercialization award program.
A recent study by researchers at the University of Miami, Miami VA Healthcare System and Express Gene and published on the preprint server medRxiv in September 2020 reports on the prognostic significance of the anti-N Immunoglobulin G (IgG) antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
The European Medicines Agency (EMA), the equivalent of the U.S. Food and Drug Administration, has approved the use of the hollow fiber system for the development of drugs to treat and prevent tuberculosis (TB).
Vertex Pharmaceuticals Incorporated today announced that it has entered into an agreement to sell 11,500,000 shares of its common stock in an underwritten offering at a price to the public of $38.50 per share, which would result in aggregate gross proceeds of $442.8 million.
Understanding the genetic mutations and protein changes that take place in the progression of cancer is key to its treatment. Mutations in the gene TP53 and concomitant mutant p53 proteins in cancer cells have become notorious over the course of multiple studies of several different types of cancers.
› Verified 5 days ago
Stephanie Sutton, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 550 N 19th St, Lincoln, NE 68588 Phone: 402-472-5000 | |
Dr. Walter J Duffy, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8101 O St, Suite 300, Lincoln, NE 68510 Phone: 402-476-6060 Fax: 402-476-6809 | |
Soa Yuc Lee, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 600 S 70th St, Lincoln, NE 68510 Phone: 402-489-3802 | |
Dianna M Clyne, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4444 South 86th St, Suite 102, Lincoln, NE 68526 Phone: 402-476-7557 Fax: 402-769-9912 | |
Michael William Vavra, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2222 S 16th St Ste 340, Lincoln, NE 68502 Phone: 402-483-8534 Fax: 402-483-8531 | |
Zakaria Siddiqui, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2221 S 17th St, Suite 202, Lincoln, NE 68502 Phone: 402-483-8555 Fax: 402-483-8554 | |
Ana Luisa Delgado, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 7441 O St Ste 104, Lincoln, NE 68510 Phone: 402-853-0993 Fax: 402-853-0197 |